Home » Telaprevir, Boceprevir May Become Trial Standard of Care for Hepatitis C
Telaprevir, Boceprevir May Become Trial Standard of Care for Hepatitis C
Recently approved hepatitis C drugs have improved treatment so much that future clinical trials of drugs may have to be held to their standards, according to an FDA official.
Clinical Trials Advisor
Clinical Trials Advisor
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May